Third Coast Therapeutics, Inc. — Form D
Third Coast Therapeutics, Inc. of EVANSTON, IL, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-05. The offering totals $1.2M, of which $50K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-06-05
- Form: D
- Accession: 0001706603-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $50K
- Remaining: $1.1M
- Minimum investment: $5K
- Investors: 3
- Date of first sale: 2017-02-23
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-288032
Issuer
- Name: Third Coast Therapeutics, Inc.
- CIK: 0001706603
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 600 DAVIS STREET, EVANSTON, IL, 60201-4488
- Phone: 6087725878
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Karl Scheidt | Director | Evanston, IL |
| Raymond Bergan | Director | Portland, OR |
| Joseph Luminiello | Director | Tower Lakes, IL |
| Joseph Luminiello | Executive Officer | Tower Lakes, IL |
Other filings by this issuer (1)
More